HILS logo

Hillstream BioPharma (HILS) EBIT

Annual EBIT

-$6.88 M
-$5.51 M-400.36%

December 31, 2022


Summary


Performance

HILS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILSprofitabilitymetrics:

Quarterly EBIT

-$2.33 M
+$351.80 K+13.12%

June 30, 2023


Summary


Performance

HILS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILSprofitabilitymetrics:

TTM EBIT

-$8.91 M
-$693.50 K-8.44%

June 30, 2023


Summary


Performance

HILS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILSprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

HILS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-400.4%-42.4%-895.8%
3 y3 years-374.5%-560.7%-2425.2%
5 y5 years-374.5%-560.7%-2425.2%

HILS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+400.4%at low-186.0%+15.1%+1325.7%at low
5 y5-year+400.4%at low-186.0%+15.1%+2425.2%at low
alltimeall time+400.4%at low-186.0%+15.1%+2425.2%at low

Hillstream BioPharma EBIT History

DateAnnualQuarterlyTTM
Jun 2023
-
-$2.33 M(-13.1%)
-$8.91 M(+8.4%)
Mar 2023
-
-$2.68 M(+51.8%)
-$8.21 M(+19.3%)
Dec 2022
-$6.88 M(+400.4%)
-$1.77 M(-17.0%)
-$6.88 M(+186.2%)
Sep 2022
-
-$2.13 M(+30.0%)
-$2.40 M(+168.8%)
Jun 2022
-
-$1.64 M(+21.1%)
-$894.40 K(+43.2%)
Mar 2022
-
-$1.35 M(-149.8%)
-$624.70 K(-54.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$1.38 M(-36.6%)
$2.71 M(-539.0%)
-$1.38 M(-73.9%)
Sep 2021
-
-$617.60 K(-54.8%)
-$5.28 M(+5.3%)
Jun 2021
-
-$1.37 M(-35.0%)
-$5.01 M(+37.5%)
Mar 2021
-
-$2.10 M(+76.7%)
-$3.64 M(+136.3%)
Dec 2020
-$2.17 M(+49.7%)
-$1.19 M(+237.3%)
-$1.54 M(+337.3%)
Sep 2020
-
-$352.70 K
-$352.70 K
Dec 2019
-$1.45 M
-
-

FAQ

  • What is Hillstream BioPharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Hillstream BioPharma?
  • What is Hillstream BioPharma annual EBIT year-on-year change?
  • What is Hillstream BioPharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Hillstream BioPharma?
  • What is Hillstream BioPharma quarterly EBIT year-on-year change?
  • What is Hillstream BioPharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Hillstream BioPharma?
  • What is Hillstream BioPharma TTM EBIT year-on-year change?

What is Hillstream BioPharma annual earnings before interest & taxes?

The current annual EBIT of HILS is -$6.88 M

What is the all time high annual EBIT for Hillstream BioPharma?

Hillstream BioPharma all-time high annual earnings before interest & taxes is -$1.38 M

What is Hillstream BioPharma annual EBIT year-on-year change?

Over the past year, HILS annual earnings before interest & taxes has changed by -$5.51 M (-400.36%)

What is Hillstream BioPharma quarterly earnings before interest & taxes?

The current quarterly EBIT of HILS is -$2.33 M

What is the all time high quarterly EBIT for Hillstream BioPharma?

Hillstream BioPharma all-time high quarterly earnings before interest & taxes is $2.71 M

What is Hillstream BioPharma quarterly EBIT year-on-year change?

Over the past year, HILS quarterly earnings before interest & taxes has changed by -$693.50 K (-42.37%)

What is Hillstream BioPharma TTM earnings before interest & taxes?

The current TTM EBIT of HILS is -$8.91 M

What is the all time high TTM EBIT for Hillstream BioPharma?

Hillstream BioPharma all-time high TTM earnings before interest & taxes is -$352.70 K

What is Hillstream BioPharma TTM EBIT year-on-year change?

Over the past year, HILS TTM earnings before interest & taxes has changed by -$8.01 M (-895.81%)